Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services | News
Search Refinements

Contract Services News

View news from other Pharmaceutical sectors:
136-150 of 2369 results
Moberg Pharma, Cadila sign deal for late-stage development of BUPI
By PBR Staff Writer
Moberg Pharma and Cadila Pharmaceuticals have signed an agreement for late-stage development and commercialization of BUPI, a novel lozenge formulation of bupivacaine for pain management in oral mucositis patients.
Contract Research & Services > Contract Services > News
Theratechnologies, TaiMed Biologics sign distribution deal for Ibalizumab
Theratechnologies and TaiMed Biologics have announced a 12-year collaboration agreement to market and distribute ibalizumab in the US and in Canada.
Contract Research & Services > Contract Services > News
Kite Pharma, Genentech partner to evaluate KTE-C19 and atezolizumab combination in NHL
By PBR Staff Writer
Kite Pharma is collaborating with Roche's subsidiary Genentech to evaluate two novel immunotherapies for patients with non-Hodgkin lymphoma (NHL).
Contract Research & Services > Contract Services > News
GSK, Miltenyi Biotec forge cell and gene therapy alliance
By PBR Staff Writer
UK pharmaceutical giant GlaxoSmithKline (GSK) and Germany-based Miltenyi Biotec are collaborating on cell and gene therapy.
Contract Research & Services > Contract Services > News
Orexigen agrees to acquire US rights to Contrave obesity pill from Takeda
By PBR Staff Writer
Orexigen Therapeutics has signed an agreement with Takeda Pharmaceutical Company to acquire the US rights to Contrave anti-obesity prescription medicine.
Contract Research & Services > Contract Services > News
SRI International wins National Cancer Institute contract for PREVENT cancer program
SRI International has been awarded a contract of up to $19.8m from the National Cancer Institute (NCI) PREVENT Cancer Preclinical Drug Development Program to support the development of potential cancer preventive agents or vaccines.
Contract Research & Services > Contract Services > News
Bristol-Myers Squibb, LabCentral partner to support biotech startup companies
Bristol-Myers Squibb and LabCentral have partnered in Cambridge, Massachusetts to support biotech startup companies.
Contract Research & Services > Contract Services > News
AstraZeneca to sell Moventig's European marketing rights to ProStrakan
By PBR Staff Writer
AstraZeneca has agreed to sell the European marketing rights for the opioid-induced constipation (OIC) drug Moventig to ProStrakan, a unit of Japanese biopharmaceutical company Kyowa Hakko Kirin.
Contract Research & Services > Contract Services > News
Exelixis, Ipsen partner to develop cabozantinib in regions Outside US, Canada and Japan
Exelixis and Ipsen jointly announced an exclusive licensing agreement for the commercialization and further development of cabozantinib, Exelixis’ lead oncology drug.
Contract Research & Services > Contract Services > News
Mitsubishi Tanabe Pharma inks licensing deal with A. Menarini Asia-Pacific for Spedra (Avanafil)
Mitsubishi Tanabe Pharma, and Singapore-based A. Menarini Asia-Pacific Holdings have entered into a licensing agreement to commercialize and promote SPEDRA (avanafil).
Contract Research & Services > Contract Services > News
Baxalta, Precision BioSciences partner to develop CAR T therapies
By PBR Staff Writer
Baxalta and Precision BioSciences have established global genome editing collaboration in immuno oncology.
Contract Research & Services > Contract Services > News
McKesson agrees to acquire two cancer care companies for $1.2bn
By PBR Staff Writer
McKesson has agreed to acquire two privately held cancer care companies, Vantage Oncology and Biologics, in two transactions totaling $1.2bn.
Contract Research & Services > Contract Services > News
Gilead Sciences launches new grants program to support HIV cure
Gilead Sciences announced that it will provide grants for up to three years to academic institutions, nonprofit organizations and community groups engaged in HIV cure activities.
Contract Research & Services > Contract Services > News
Eisai, PIQUR sign deal to investigate Halaven and PQR309 in patients with TNBC
Eisai and PIQUR Therapeutics have signed an agreement to conduct a Phase 1/2b clinical study to investigate PQR309 in combination with Halaven® (eribulin) in patients with triple-negative breast cancer (TNBC).
Contract Research & Services > Contract Services > News
Philogen expands research and development agreement with AbbVie
Philogen has entered into a second collaboration with AbbVie to discover and develop novel types of armed antibody products.
Contract Research & Services > Contract Services > News
136-150 of 2369 results